Respiratory Medicine
Volume 104, Issue 2 , Pages 228-236 , February 2010

Tiotropium 5μg via Respimat and 18μg via HandiHaler; efficacy and safety in Japanese COPD patients

  • M. Ichinose

      Affiliations

    • Wakayama Medical University, Wakayama, Japan
    • Corresponding Author InformationCorresponding author at: Third Department of Internal Medicine, Wakayama Medical University, 811-1, Kimiidera, Wakayama 641 8509, Japan. Tel.: +81 73 441 0619; fax: +81 73 447 2201.
    • ,
  • T. Fujimoto

      Affiliations

    • Nippon Boehringer Ingelheim, Japan
    • Tsuyoshi Fujimoto, 2-1-1 Osaki, Shinagawa-ku, Tokyo 141 6017, Japan.
    • ,
  • Y. Fukuchi

      Affiliations

    • Juntendo University School of Medicine, Tokyo, Japan
    • Yoshinosuke Fukuchi, 2-9-8-901 Hongo, Bunkyo-ku, Tokyo 113 0033, Japan.

Received 19 August 2009 ,Accepted 17 November 2009.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

PII: S0954-6111(09)00375-8

doi: 10.1016/j.rmed.2009.11.011

Respiratory Medicine
Volume 104, Issue 2 , Pages 228-236 , February 2010

Article Tools

* Image Usage & Resolution